Global Zinc Finger Nuclease Technology Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Zinc Finger Nuclease Technology Market Insights, Forecast to 2034
Zinc-finger nucleases (ZFNs) are artificial restriction enzymes generated by fusing a zinc finger DNA-binding domain to a DNA-cleavage domain. Zinc finger domains can be engineered to target specific desired DNA sequences and this enables zinc-finger nucleases to target unique sequences within complex genomes. By taking advantage of endogenous DNA repair machinery, these reagents can be used to precisely alter the genomes of higher organisms. Alongside CRISPR/Cas9 and TALEN, ZFN is a prominent tool in the field of genome editing.
Market Analysis and InsightsGlobal Zinc Finger Nuclease Technology Market
Global Zinc Finger Nuclease Technology market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Zinc Finger Nuclease Technology industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Zinc Finger Nuclease Technology key companies include Sigma-Aldrich, Sangamo Therapeutics, Labomics, Thermo Fisher Scientific and Gilead, etc. Sigma-Aldrich, Sangamo Therapeutics, Labomics are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Zinc Finger Nuclease Technology were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Zinc Finger Nuclease Technology market and estimated to attract more attentions from industry insiders and investors.
Zinc Finger Nuclease Technology can be divided into Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other, etc. Cell Line Engineering is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Zinc Finger Nuclease Technology is widely used in various fields, such as Biotechnology Companies, Pharmaceutical Companies, Hospital Laboratory and Diagnostic Laboratory and Academic and Research Institutes, etc. Biotechnology Companies provides greatest supports to the Zinc Finger Nuclease Technology industry development. In 2022, global % revenue of Zinc Finger Nuclease Technology went into Biotechnology Companies filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Zinc Finger Nuclease Technology market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Zinc Finger Nuclease Technology market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Sigma-Aldrich
Sangamo Therapeutics
Labomics
Thermo Fisher Scientific
Gilead
Segment by Type
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other
Biotechnology Companies
Pharmaceutical Companies
Hospital Laboratory and Diagnostic Laboratory
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Zinc Finger Nuclease Technology introduction, etc. Zinc Finger Nuclease Technology Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Zinc Finger Nuclease Technology
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Zinc Finger Nuclease Technology Market
Global Zinc Finger Nuclease Technology market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Zinc Finger Nuclease Technology industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Zinc Finger Nuclease Technology key companies include Sigma-Aldrich, Sangamo Therapeutics, Labomics, Thermo Fisher Scientific and Gilead, etc. Sigma-Aldrich, Sangamo Therapeutics, Labomics are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Zinc Finger Nuclease Technology were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Zinc Finger Nuclease Technology market and estimated to attract more attentions from industry insiders and investors.
Zinc Finger Nuclease Technology can be divided into Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other, etc. Cell Line Engineering is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Zinc Finger Nuclease Technology is widely used in various fields, such as Biotechnology Companies, Pharmaceutical Companies, Hospital Laboratory and Diagnostic Laboratory and Academic and Research Institutes, etc. Biotechnology Companies provides greatest supports to the Zinc Finger Nuclease Technology industry development. In 2022, global % revenue of Zinc Finger Nuclease Technology went into Biotechnology Companies filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Zinc Finger Nuclease Technology market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Zinc Finger Nuclease Technology market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Sigma-Aldrich
Sangamo Therapeutics
Labomics
Thermo Fisher Scientific
Gilead
Segment by Type
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Hospital Laboratory and Diagnostic Laboratory
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Zinc Finger Nuclease Technology introduction, etc. Zinc Finger Nuclease Technology Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Zinc Finger Nuclease Technology
Chapter 13Methodology and Data Sources adopted by MRAResearch